These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30404037)

  • 21. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria.
    Liang J; Shi C; Dupont WD; Salaria SN; Huh WJ; Correa H; Roland JT; Perri RE; Washington MK
    Mod Pathol; 2021 Mar; 34(3):592-602. PubMed ID: 32958831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease.
    Witters P; Libbrecht L; Roskams T; Boeck KD; Dupont L; Proesmans M; Vermeulen F; Strandvik B; Lindblad A; Stéphenne X; Sokal E; Gosseye S; Heye S; Maleux G; Aerts R; Monbaliu D; Pirenne J; Hoffman I; Nevens F; Cassiman D
    Hepatology; 2011 Mar; 53(3):1064-5. PubMed ID: 21374682
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report.
    Hitawala AA; Redmond C; Cowen EW; Kleiner DE; Hasni S; Heller T
    J Investig Med High Impact Case Rep; 2023; 11():23247096231171251. PubMed ID: 37132021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction.
    Vallonthaiel AG; Baloda V; Singh L; Yadav R; Kilambi R; Battu S; Sreenivas V; Pal S; Acharya SK; DattaGupta S; Shalimar ; Das P
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S127-S135. PubMed ID: 34135154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portal vein measurement by ultrasonography in patients with long-standing cystic fibrosis: preliminary observations.
    Kumari-Subaiya S; Gorvoy J; Phillips G; Ross P; Riddelsberger MM
    J Pediatr Gastroenterol Nutr; 1987; 6(1):71-8. PubMed ID: 3540261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural aspects of the liver in patients with biliary disease and portal hypertension.
    Weinbren K; Hadjis NS; Blumgart LH
    J Clin Pathol; 1985 Sep; 38(9):1013-20. PubMed ID: 4044871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver cirrhosis and portal hypertension in cystic fibrosis.
    Efrati O; Barak A; Modan-Moses D; Augarten A; Vilozni D; Katznelson D; Szeinberg A; Yahav J; Bujanover Y
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1073-8. PubMed ID: 14501614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of endothelial-mesenchymal transition in idiopathic portal hypertension.
    Sato Y; Nakanuma Y
    Histol Histopathol; 2013 Feb; 28(2):145-54. PubMed ID: 23275299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.
    Chougule A; Rastogi A; Maiwall R; Bihari C; Sood V; Sarin SK
    Hepatol Int; 2018 Mar; 12(2):158-166. PubMed ID: 29651703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic portal hypertension and its pathology.
    Okudaira M; Ohbu M; Okuda K
    Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary Atresia Patients With Successful Kasai Portoenterostomy Can Present With Features of Obliterative Portal Venopathy.
    Patel KR; Harpavat S; Khan Z; Dhingra S; Quintanilla N; Firan M; Goss J
    J Pediatr Gastroenterol Nutr; 2020 Jul; 71(1):91-98. PubMed ID: 32187144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obliterative portal venopathy: portal hypertension is not always present at diagnosis.
    Cazals-Hatem D; Hillaire S; Rudler M; Plessier A; Paradis V; Condat B; Francoz C; Denninger MH; Durand F; Bedossa P; Valla DC
    J Hepatol; 2011 Mar; 54(3):455-61. PubMed ID: 21087805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obliterative portal venopathy: a study of 48 children.
    Franchi-Abella S; Fabre M; Mselati E; De Marsillac ME; Bayari M; Pariente D; Jacquemin E; Bernard O
    J Pediatr; 2014 Jul; 165(1):190-193.e2. PubMed ID: 24768253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver cirrhosis and portal hypertension in cystic fibrosis.
    Fustik S
    Srp Arh Celok Lek; 2013; 141(11-12):764-9. PubMed ID: 24502094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porto-Sinusoidal Vascular Disease: A Concise Updated Summary of Epidemiology, Pathophysiology, Imaging, Clinical Features, and Treatments.
    Jin SJ; Choi WM
    Korean J Radiol; 2023 Jan; 24(1):31-38. PubMed ID: 36606618
    [No Abstract]   [Full Text] [Related]  

  • 40. Multimodality imaging of obliterative portal venopathy: what every radiologist should know.
    Arora A; Sarin SK
    Br J Radiol; 2015 Feb; 88(1046):20140653. PubMed ID: 25514699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.